Bharti reported a 5/8% beat on Ebitda/adjusted net profits, respectively, for the Sep-17 quarter. 60% of Ebitda beat came from Africa (17% higher than estimates), while India mobile Ebitda was 4% ahead.
We recently met with Maruti management and came back quite positive on the near-term outlook with expectations of a strong Q2 as margins improve from Q1 levels on better product mix (higher ASP and lower discounts) and operat
We recently met with Shriram Transport Finance’s (SHTF) MD and CEO, Umesh Revankar, who remarked that business remains steady post GST, with normal freight rates and cash flows for truckers translating into good collections
Indian pharma stocks have de-rated by 10% over the last one year, but with price erosion expected to increase, a further de-rating is expected. Multiple triggers for further de-rating Higher price erosion leads to lower earn